Gene amplification in cancer
- PMID: 16787682
- DOI: 10.1016/j.tig.2006.06.007
Gene amplification in cancer
Abstract
Gene amplification is a copy number increase of a restricted region of a chromosome arm. It is prevalent in some tumors and is associated with overexpression of the amplified gene(s). Amplified DNA can be organized as extrachromosomal elements, as repeated units at a single locus or scattered throughout the genome. Common chromosomal fragile sites, defects in DNA replication or telomere dysfunction might promote amplification. Some regions of amplification are complex, yet elements of the pattern are reproduced in different tumor types. A genetic basis for amplification is suggested by its relative frequency in some tumor subtypes, and its occurrence in "early" preneoplastic lesions. Clinically, amplification has prognostic and diagnostic usefulness, and is a mechanism of acquired drug resistance.
Similar articles
-
Extrachromosomal double minutes and chromosomal homogeneously staining regions as probes for chromosome research.Cytogenet Genome Res. 2009;124(3-4):312-26. doi: 10.1159/000218135. Epub 2009 Jun 25. Cytogenet Genome Res. 2009. PMID: 19556783 Review.
-
Oncogene amplification in solid tumors.Semin Cancer Biol. 1999 Aug;9(4):319-25. doi: 10.1006/scbi.1999.0126. Semin Cancer Biol. 1999. PMID: 10448118 Review.
-
Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562 - Molecular characterization of FRA2H and localization of a new CFS FRA2S.Cancer Lett. 2010 Dec 18;299(1):37-44. doi: 10.1016/j.canlet.2010.08.001. Epub 2010 Sep 18. Cancer Lett. 2010. PMID: 20851513
-
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.Oncogene. 2008 May 22;27(23):3256-64. doi: 10.1038/sj.onc.1210989. Epub 2007 Dec 17. Oncogene. 2008. PMID: 18084328
-
Comprehensive profiling of 8p11-12 amplification in breast cancer.Mol Cancer Res. 2005 Dec;3(12):655-67. doi: 10.1158/1541-7786.MCR-05-0128. Mol Cancer Res. 2005. PMID: 16380503
Cited by
-
IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer.J Cancer Res Clin Oncol. 2024 Jul 25;150(7):363. doi: 10.1007/s00432-024-05868-2. J Cancer Res Clin Oncol. 2024. PMID: 39052108 Free PMC article.
-
Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.Mol Carcinog. 2016 May;55(5):977-90. doi: 10.1002/mc.22341. Epub 2015 Jul 24. Mol Carcinog. 2016. PMID: 26207617 Free PMC article.
-
Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.Cell Death Dis. 2016 Oct 27;7(10):e2442. doi: 10.1038/cddis.2016.346. Cell Death Dis. 2016. PMID: 27787520 Free PMC article.
-
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation.Commun Biol. 2024 Jan 5;7(1):18. doi: 10.1038/s42003-023-05664-7. Commun Biol. 2024. PMID: 38177713 Free PMC article.
-
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.PLoS Med. 2010 Jul 27;7(7):e1000315. doi: 10.1371/journal.pmed.1000315. PLoS Med. 2010. PMID: 20668658 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
